GMED

60.57

0.61% 0.37

Handel nachbörslich: 60.57

Globus Medical Inc (GMED)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$60.20

Offen:

$60.14

24-Stunden-Volumen:

1.75M

Relative Volume:

1.22

Marktkapitalisierung:

$8.32B

Einnahmen:

$2.51B

Nettoeinkommen (Verlust:

$185.56M

KGV:

45.20

EPS:

1.34

Netto-Cashflow:

$517.59M

1W Leistung:

+4.09%

1M Leistung:

+2.73%

6M Leistung:

-25.98%

1J Leistung:

-10.99%

1-Tages-Spanne:

$59.91

$60.97

1-Wochen-Bereich:

$57.78

$61.29

52-Wochen-Spanne:

$54.48

$94.93

Globus Medical Inc Stock (GMED) Company Profile

Firmenname

Globus Medical Inc

Sektor

Healthcare (1166)

Branche

Medical Devices (148)

Telefon

610-930-1800

Adresse

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Mitarbeiter

5,300

Twitter

@GlobusMedical

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

GMED's Discussions on Twitter

Vergleichen Sie GMED mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GMED Globus Medical Inc	60.57	8.32B	2.51B	185.56M	517.59M	1.34
ABT Abbott Laboratories	134.11	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	103.63	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	391.81	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	88.28	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	77.02	44.46B	5.54B	4.18B	623.10M	7.00

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-27	Herabstufung	BTIG Research	Buy → Neutral
2025-01-10	Hochstufung	BofA Securities	Underperform → Neutral
2024-12-02	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-08-07	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-05-20	Hochstufung	Piper Sandler	Neutral → Overweight
2024-03-18	Hochstufung	BTIG Research	Neutral → Buy
2023-10-20	Eingeleitet	ROTH MKM	Buy
2023-09-19	Hochstufung	Stifel	Hold → Buy
2023-03-30	Hochstufung	Canaccord Genuity	Hold → Buy
2023-02-13	Herabstufung	BofA Securities	Buy → Underperform
2023-02-10	Herabstufung	BTIG Research	Buy → Neutral
2023-02-10	Herabstufung	Loop Capital	Buy → Hold
2023-02-10	Herabstufung	Needham	Buy → Hold
2023-02-10	Herabstufung	Truist	Buy → Hold
2023-02-10	Herabstufung	Wells Fargo	Overweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Buy
2022-04-13	Fortgesetzt	Truist	Buy
2022-03-28	Eingeleitet	Wells Fargo	Overweight
2022-01-04	Hochstufung	Piper Sandler	Neutral → Overweight
2021-12-13	Hochstufung	BofA Securities	Underperform → Buy
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-10-29	Eingeleitet	Loop Capital	Buy
2021-02-18	Fortgesetzt	Needham	Buy
2020-12-08	Eingeleitet	Citigroup	Buy
2020-10-20	Eingeleitet	Stifel	Hold
2020-08-06	Bestätigt	Needham	Buy
2020-08-06	Hochstufung	Northland Capital	Market Perform → Outperform
2020-07-21	Eingeleitet	Northland Capital	Market Perform
2020-07-06	Herabstufung	Piper Sandler	Overweight → Neutral
2020-05-08	Bestätigt	Needham	Buy
2020-03-18	Hochstufung	BTIG Research	Neutral → Buy
2020-01-08	Eingeleitet	SunTrust	Buy
2019-12-12	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-08-02	Bestätigt	Needham	Buy
2019-05-24	Herabstufung	Wells Fargo	Outperform → Market Perform
2019-05-03	Bestätigt	Needham	Buy
2019-02-28	Hochstufung	UBS	Neutral → Buy
2019-01-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-08-02	Bestätigt	Needham	Buy
2018-06-27	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-06-01	Eingeleitet	Cantor Fitzgerald	Overweight
2018-05-03	Bestätigt	Needham	Buy
2018-04-04	Hochstufung	Needham	Hold → Buy

Alle ansehen

Globus Medical Inc Aktie (GMED) Neueste Nachrichten

Jun 18, 2025

August 15th Options Now Available For Globus Medical (GMED) - Nasdaq

Jun 18, 2025

2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance

Jun 18, 2025

Jun 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.GMED - PR Newswire

Jun 17, 2025

Jun 15, 2025

Globus Medical Announces $500M Share Repurchase Program to Boost Shareholder Value - MSN

Jun 15, 2025

Is Globus Medical, Inc.'s (NYSE:GMED) Recent Price Movement Underpinned By Its Weak Fundamentals? - simplywall.st

Jun 15, 2025

Jun 12, 2025

Globus Medical’s SWOT analysis: robotic spine leader’s stock poised for growth By Investing.com - Investing.com South Africa

Jun 12, 2025

Globus Medical’s SWOT analysis: robotic spine leader’s stock poised for growth - Investing.com

Jun 12, 2025

Jun 11, 2025

Medical Devices & SuppliesSpecialty Stocks Q1 Recap: Benchmarking Globus Medical (NYSE:GMED) - Yahoo Finance

Jun 11, 2025

Globus Medical, Inc. (NYSE:GMED) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 11, 2025

Jun 10, 2025

Globus Medical (GMED) Poised for Growth Despite Recent Challenge - GuruFocus

Jun 10, 2025

Globus Medical (GMED) Poised for Growth Despite Recent Challenges | GMED Stock News - GuruFocus

Jun 10, 2025

Parallel Advisors LLC Purchases 193 Shares of Globus Medical, Inc. (NYSE:GMED) - Defense World

Jun 10, 2025

Jun 09, 2025

Total Disc Replacement Market Detailed in New Report - openPR.com

Jun 09, 2025

GAMMA Investing LLC Raises Position in Globus Medical, Inc. (NYSE:GMED) - Defense World

Jun 09, 2025

Jun 06, 2025

Collegeville Office Buildings Sell to Globus Medical with Staggering Price Cut - VISTA.Today

Jun 06, 2025

Jun 05, 2025

Globus Medical Approves Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025

Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential - Yahoo Finance

Jun 05, 2025

Jun 04, 2025

Adult Spinal Deformity Market Detailed in New Research Report - openPR.com

Jun 04, 2025

Jun 03, 2025